Cardiovascular abnormalities represent the major cause of death in patients with acromegaly. We evaluated cardiac structure, function, and energy status in adult transgenic mice overexpressing bovine GH (bGH) gene.
C ARDIOVASCULAR DISEASE IS the major cause of death in patients with acromegaly (1, 2) heart failure with signs and symptoms of both left and right ventricular impairment is a common late complication of acromegaly (3, 4) . Other associated complications such as hypertension, diabetes mellitus, and coronary artery disease also exert profound influences on the acromegalic heart. However, a deterioration of heart function and structure may also develop in acromegalic patients in the absence of hypertension, diabetes, or other predisposing factors (5, 6) and the concept of a specific acromegalic cardiomyopathy has been proposed. The mechanisms underlying the cardiac dysfunction in acromegaly are still not clear. A hyperkinetic syndrome with increased cardiac output and decreased peripheral resistance characterizes the initial stage of the disease (7) . These findings suggesting short-term stimulatory effects of GH on heart function are supported by similar observations in normal healthy volunteers treated with GH (8) and in a widely used rat model of GH hypersecretion due to a GH producing tumor (9 -11) . The mechanisms for the transition of this hyperkinetic syndrome into a gradually developing deterioration of heart function as the acromegalic disease progresses are less well characterized, although increased myocardial fibrosis has been implicated to play a potential role (12) . Accumulating evidence demonstrates the importance of GH and/or its local effector insulin-like growth factor I (IGF-I) at the molecular and cellular level for normal myocardial function (13, 14) . IGF-I is synthesized in multiple tissues including the heart and some of the effects have been suggested to be paracrine or autocrine (13) (14) (15) (16) . Both high levels of GH (1, 2) as well as GH-deficiency (17, 18) , are associated with increased cardiovascular morbidity and mortality.
Transgenic technology has provided the research community with different lines of transgenic mice (TG) that have integrated rat, human, or bovine GH gene under the control of an independent inducible system into their genome. They express very high level of the foreign GH and have been extensively used to investigate the process of growth and the effect of excess GH in many organs and tissues (19) . There is a lack of information regarding the cardiovascular physiology of these transgenic mice. Therefore, using adult transgenic mice overexpressing bovine GH (bGH) gene we aimed to assess in vivo, the effects of long-term exposure to high levels of circulating concentrations of GH on cardiac structure, function and energy status. Our hypothesis was that deterioration of cardiac performance could be linked to alterations in energy metabolism. To test that we combined two noninvasive tools echocardiography and in vivo volumeselective 31 P magnetic resonance spectroscopy ( 31 P MRS).
Materials and Methods Animals
The TG mice were generated as previously described (20) . A BstEIIEcoRI fragment from the plasmid mtbGH2016 (generously provided by Dr. Palmiter, University of Washington) was used. This DNA fragment contains the metallothionein promoter (Mt) linked to a sequence encoding bGH was injected into pronucleus of C57B1/6J ϫ CBA-f2 embryos by standard microinjection procedure. Mice that had integrated the transgene were identified with PCR analysis (PCR) of DNA from tail biopsy specimens obtained 3 weeks after birth using one PCR primer located in the Mt promoter and another in the bGH gene.
After performing echocardiography and/or 31 PMRS, the experiment was terminated with an overdose of ip chloral hydrate; the blood samples were collected; hearts were excised and the atria and vessels dissected. Free biventricular tissue was weighed and frozen in liquid nitrogen and stored at Ϫ80 C. Liver and kidneys were also weighed.
The study protocol was approved by the Animal Ethics Committee of the Gothenburg's University and conducted in accordance with NIH guidelines for use of experimental animals.
Echocardiography
Twenty offspring of Mt-bGH transgenic male mice derived from one founder animal were investigated, 10 transgenic and 10 eight-month-old nontransgenic female mice. Mice were anesthetized with isoflurane (0.4 -0.6%) and mixture of O 2 and N 2 O 2:1, using a nose mask. The anterior chest was shaved and ECG leads were placed on extremities. A warming pad was used to maintain body temperature. Cardiac ultrasound studies were performed using a commercially available ultrasonograph (GE Vingmed Ultrasonograph, West Milwaukee, WI) by methods previously validated (21, 22) . A 10 MHz linear transducer was used for obtaining of two-dimensional parasternal short axis imaging closed to the papillary muscles. This served as a guide for M-mode tracing. For pulsed-wave Doppler recordings, the minimum sample size was used and the pulse frequency of 5 MHz to record the estimated peak left ventricle (LV) outflow tract velocity and the mitral inflow velocities. All tracings were recorded at a sweep of 200 mm/s and were stored in magnetic optical discs for off-line measurements. Off-line measurements were done using image analysis system (Echo Pac 5.4, Ving Med) by one observer without prior knowledge of the type of mice.
Data analysis
M-mode measurements of LV internal diameters and wall thickness in diastole and systole were made by using the leading-edge convention of the American Society of Echocardiography. End diastole was taken at the onset of the QRS complex, and end systole was taken at the peak inward of interventricular septum (IVS) motion. Four or more beats were averaged for each measurement.
LV fraction shortening (FS) was calculated as follows. (LVIDd-LVIDs)/ LVIDd ϫ 100 where LVIDd and LVIDs are respectively LV internal diameters in diastole and systole. Ejection fraction (EF), relative wall thickness (RWT), velocity of circumferential shortening (Vcf) were calculated by formulas described elsewhere (23 
P Magnetic resonance spectroscopy
Twelve mice (6 TG and 6 nontransgenic), randomly chosen were investigated noninvasively with 31 P-MRS for evaluation of cardiac energy metabolism.
Mice were given induction anesthesia with fentanyl/fluanizon (Hypnorm, Janssen Pharmaceuticals, Beerse, Belgium) 0.5 mg/kg and diazepam (Stesolid) 2.5 mg/kg ip and kept anesthetized by continued anesthesia with isoflurane (0.4 -0.6%) in the mixture of O 2 /N 2 O 2:1, at the flow rate 1-2 liters/min). Body temperature was maintained constant (37 C) during the investigation. Cardiac gated MR imaging and spectroscopy were performed on a 2.35 T horizontal magnet with a 20 cm bore (Bruker BioSpec Products, Inc., Faellanden, Switzerland, 24/30). A double tuned ( 1 H and 31 P) Helmholtz coil of 2 cm was used for transmission and reception of radiofrequencies. Anesthetized mouse was placed between Helmholtz coil in a prone position in such a way that chest region was lying in the B 1 field. More technical details about the localization strategy were given in our earlier investigations on the skeletal muscle (24) . Cardiac-gated gradient echo method was used for imaging of the thoraco-abdominal region in transversal and sagittal plane (5 slices each with thickness of 1.5 mm). The volume of interest (VOI) was 8 ϫ 4 ϫ 4 mm (128 l) and included as much of the LV ventricle as possible. The position of the VOI was defined both in sagittal and transversal plane. Care was taken not to include parts of diaphragm, chest skeletal muscles, and liver into VOI. After selecting the VOI, the magnetic field homogeneity was further optimized by localized shimming using STEAM localization method. Cardiac-gated Image Selected In vivo Spectroscopy (ISIS) was then employed for acquisition of 31 P MR spectra of the heart. Acquisition parameters were 4096 scans with repetition time 2.5 sec, giving a total scan time of approximately 3 h.
To correct for blood contamination of the ATP signal, 31 P MRS of the mouse blood was performed. The correction of ATP was then calculated according to the formula: ATP ϭ calculated ATP Ϫ [0.5 ϫ (ATP/2.3 DPG) blood ϫ 2,3-DPG heart )] (25, 26) .
Blood pressure measurement
Animals were anesthetized with chloral hydrate (459 g/g ip). The left carotid artery was cannulated and connected to a Statham P23 DC transducer. Mean arterial blood pressure was recorded on a Grass Model 7D polygraph. Blood pressure values were calculated as means of 30 samples.
Serum IGF-I
Serum was prepared and frozen at Ϫ20 C until assayed for measurements of IGF-I level. The serum concentration of IGF-I was determined by a hydrochlorid acid-ethanol extraction RIA using human IGF-I for labeling (Nichols Institute Diagnostics, San Juan Capistrano, CA). The assay was performed according to the manufacturer's protocol after centrifugation of precipitated serum proteins at ϩ4 C followed by neutralization with Tris base and another centrifugation at ϩ4 C.
Histologic examination
The whole hearts were cut serially from apex to the base (n ϭ 6). Every second slice was paraffin embedded. From each paraffin block a section was cut, stained with Masson's trichrome and mounted. The measurements were carried out on an IBAS system and all images used for measuring were captured with high-resolution digital camera (Progress).
Briefly, in 9 -10 systematically randomly selected high power fields, the colourmetric spectrum of blue stained fibrous tissue from sections of left ventricle was defined and its area fraction was calculated in the IBAS. Vascular profiles and subendocardial fibrous zone were excluded in the sampling procedures. The area fraction of diffuse fibrosis was expressed as percent of sampled myocardium.
Electron microscopy
Small pieces of the hearts were fixed in 2% glutaraldehyde in 0.1 m cacodylate buffer for 2 h at 4 C. After being washed in PBS (0.1 phosphate buffer) for 2 h, the tissues were postfixed with 1% osmium tetroxide for 1 h. After the dehydration with a graded series of ethanol concentration, the samples were embedded in Epon resin. Ultrathin sections were stained with uranyl acetate and examined with Tesla EM BS 500.
TUNEL stain
Sections from heart tissue, 10 m thick, were cut on a cryostat and adhered to microscopic slides. The sections were then fixed in 4% paraformaldehyde in PBS, pH 7.4. Endogenous peroxidase was quenched with preincubation of the sections in 3% H 2 O 2 in PBS for 5 min. The sections were then stained according to the TUNEL method using the ApoTag plus peroxidase kit (Oncor) according to the manufacture instructions. Thereafter the sections were counterstained with methyl green and mounted. Sections preincubated with DNase I and sections of ovary from 21-day-old rats served as positive controls.
Statistical analysis
All data are shown as mean Ϯ sd, unless otherwise stated. The significance of group differences was determined with two-sided unpaired Student's t test. A value of P Ͻ 0.05 was considered significant.
Results

Body and organ weights
Transgenic mice overexpressing bGH had significantly increased body weight compared with nontransgenic mice (Table 1) . Levels of IGF-I in serum were also higher in bGH mice. The excess of bGH affected growth of various organs to a different extent. Organ to body weight (presented as a percentage) in transgenic mice also differed significantly from those seen in controls (Table 1) . In comparison to controls, the relative organ mass in relation to BW was most pronounced for liver and kidneys followed by the heart. Macroscopic appearance of the liver was characterized by enlargement with nodular alterations. Heart weights in transgenic mice, even when normalized to body weight, were increased compared with normal controls. In four transgenics and five controls, blood pressure was successfully measured showing no difference between the two groups (mean Ϯ sem; bGH, 71 Ϯ 9 mmHg; control, 84 Ϯ 4 mmHg).
Histology
Area fraction of collagen, a measure of the concentration of interstitial fibrillar collagen, was increased in heart of transgenic mice compared with controls (Table 1) . In control heart, normal geometry and orientation between muscle fibers and mitochondria are observed. Myofibrils are separated by rows of mitochondria. The mitochondria are pleomorphic and elongated in shape with well developed cristae and outer membranes. Among them there are residual bodies with electron dense matrix and myelin figures or lipids droplets (Fig. 1a) . The ultrastructure of the transgenic mouse heart exhibits the typical morphologic pattern with one important exception. The mitochondria are swollen with dissolving of the regular cristae arrangements and giant mitochondria are occasionally seen. The outer membranes of the mitochondria are not homogeneously stained as seen in the controls although identical contrasting procedures have been used (Fig. 1b) . Occasionally confluent mitochondria are seen; then they are formed giant organelles over more than one sarcomere length. The components of the sarcoplasmatic reticulum and T systems were relatively unchanged.
TUNEL staining of the ventricles showed only occasionally labeled cells. These single cells were restricted to the interstitium. There was no difference between two studied groups.
Left ventricle geometry and function (Fig. 2, Tables 2 and 3)
The mean heart rates were similar between the groups. Absolute LV dimensions were significantly increased in bGH mice. The posterior wall thickness was mildly increased, whereas the relative wall thickness was not different between the two groups. Together, these findings indicate eccentric hypertrophy of left ventricle in transgenic mice.
Fractional shortening and velocity of circumferencial shortening and interventricular septum per cent thickening were significantly lower in the mice overexpressing bGH, marking global and regional depressed LV systolic function of these mice.
Doppler measurement did not show any difference between the groups. Early (E-wave) and late-diastolic transmitral velocity with atrial contraction (A-wave) velocities were similar in control and transgenic animals (E wave: bGH, 6 Ϯ 1 cm/sec; controls 6 Ϯ 2 cm/sec); (A wave: bGH, 3 Ϯ 1 cm/sec; controls 3 Ϯ 1 cm/sec).
P MRS
Representative spectra from a control and a transgenic mouse are illustrated in Fig. 3 . The amplitude and the area of PCr relative to ATP are lower in the heart of bGH mouse. The mean value Ϯ sem of PCr/ATP ratio are presented in Fig.  4 , showing a significant decrease of this ratio in bGH mice.
Discussion
The major findings in the present study are that long exposure to high levels of GH is associated with increased heart mass, impairment of systolic function, and decreased energy reserve in the myocardium. These findings suggest that one possible mechanism responsible for the depressed cardiac function in this model of acromegalic cardiomyopathy may be disturbances in myocardial energy metabolism.
Cardiac enlargement is a consistent finding in acromegalic heart disease, presenting with varying degree of myocardial hypertrophy (4, 5, 27) . In our animals, left ventricular mass and heart mass indexes were higher in transgenic mice compared with nontransgenic mice, marking a disproportionate growth of the heart compared with growth of the body. Echocardiographic results indicated presence of eccentric LV hypertrophy in the mice overexpressing bGH gene that was associated with increased interstitial fibrosis, a common finding in the hearts of acromegalic patients. Morphologic alterations were not only in the organ level but also in the cellular level. The ultrastructural alterations observed in the heart from bGH mice are mainly confined to the mitochondria. These include both changes in the size of the mitochondria, disarrangement of the cristae and outer membrane. Histologic data from other studies using bGH mice did not reveal pronounced pathological changes in cardiac tissue (28) . The different age of animals might explain the discrepancy between the results. Several clinical studies performed in patients with acromegaly at the early stages of the disease have demonstrated the presence of diastolic dysfunction at rest, while systolic function was normal whereas during exercise testing cardiac reserve is limited (4, 6, 27, 29) .
The systolic cardiac function evaluated in vivo was significantly depressed in the mice overexpressing bGH gene compared with controls. In present study, fraction shortening and velocity of circumferential shortening were significantly lower in transgenic mice, underlining a severe depression of systolic function. In the presence of hypertrophy and increased interstitial fibrosis, a normal Doppler diastolic inflow is unlikely. Therefore, the "normal" transmitral velocities seen in our study could be rather a pattern of pseudonormalization as result from counterbalancing influences from both abnormal relaxation and restrictive forces. Taken to- In the control mouse heart, the mitochondria vary in size but approximate a sarcomere in length and the inner membranes are arranged into closely-packed transverse cristae (stars). In contrast to controls the cristae of the mitochondria appear to be swollen in the left ventricle of the transgenic mouse (b). They lost the typical pattern seen in the control heart. The outer mitochondrial membranes are pale and poorly recognizable. Bar, 0.5 m. gether, morphological and functional similarities between our observations and clinical data made this animal model potentially suitable for studying the chronic effects of excessive GH activity in the heart.
TABLE 2. Echocardiography data: morphology
Using the rat bearing GH-secreting tumor, both an improvement (30) and deterioration (11, 31) , of cardiac performance have been reported. The positive inotropic effect of GH is known, demonstrated in vivo in normal mice (32) treated with GH for a relatively short time and in more physiological doses and in animal model of myocardial infarction (33, 34) . In vitro studies on isolated papillary muscle or papillary skinned fibers have shown improved contractile performance with significantly increment in calcium sensitivity of contractile proteins (35, 36) , explaining the positive inotropic effect of GH seen in the early phase of acromegaly, where a hyperkinetic syndrome is present.
Several characteristics make the rats with transplanted GH-secreting tumors different from patients with acromegaly (7) and bGH transgenic mice. What predominates in this rat model is a functional rather than trophic component of GH action, which may be attributed to a relatively short exposure to GH excess. The bGH transgenic mice are exposed earlier in life to high levels of GH, and the exposure to these high GH levels are more prolonged than in rats with a GH producing tumor.
Our study provides new information about cardiovascular physiology and metabolism of bGH transgenic mice. The compromised cardiac performance in transgenic mice was accompanied with substantial alteration in myocardial energy metabolism. Timsit et al. (35) has reported increased contractility with low energy expenditure in rat model of GH hypersecretion. The time of exposure to GH excess was 18 
31
P spectrum from the heart of a control mouse (a) compared with that from a transgenic mouse (b). The myocardial PCr/ATP ratio is decreased in the transgenic mouse. The prominent peak in the range of chemical shift for PDE in the spectrum from the bGH mouse heart is probably caused by the hyperlipidemia present in these mice (48) . Increased signal from 2.3DPG ϩ Pi reflects both higher blood pool contamination of the spectrum in the transgenic mouse and increased levels of Pi in the myocardium of these mice. PCr, Phosphocreatine; ␣, ␤, ␥-ATP-␣, ␤, ␥, Adenosine-3-phosphate. PDE, Phospho-di-esthers; 2,3 DPG, di-triphosphoglycerate; Pi, inorganic phosphate.
weeks, whereas in our model, cardiac tissue was exposed twice longer. Marked changes observed in our study underlined the importance of duration of exposure to GH excess. Cardiac bioenergetic status was evaluated with 31 P MRS. The validity of this method for studying the changes in highenergy phosphate metabolites in heart in normal and pathological conditions has been extensively demonstrated in animals (37) (38) (39) and in clinical studies (26, 40) .
Our preliminary data showed the feasibility of performing in vivo volume selective 31 P MRS for assessment of the cardiac energy status in the mouse heart (41) that has been confirmed from others (42) . The marked reduction of PCr/ATP ratio observed in our study reflects an imbalance in energy demand and supply. Several studies performed in different models of LV hypertrophy have shown an association between increase in LV mass and decreased PCr/ATP ratio (43, 44) . Quaife et al. (28) have shown that bGH transgenic mice are hyperinsulinemic with normal fasting glucose levels in blood. These findings are a reflection of insulin resistance that is often seen in acromegalic patients also. Disturbances in glucose metabolism, presence of hypertrophy, and increased interstitial fibrosis could affect the availability and pattern of energy substrate utilization in the myocardium. At the same time, we observed marked morphological changes of the mitochondria in the heart of transgenic mice. Increase in size and changes in the appearance of the mitochondria may be compensatory events to defective oxidative phosphorylation, as seen in mitochondria diseases (45) . Knowing the direct effect of GH on Ca 2ϩ -handling, a long-term exposure to high circulatory levels of GH might have lead to calcium overload with negative consequences on mitochondria function and integrity (46) . Nevertheless, characterization of the abnormalities of mitochondria function is needed to clarify the issue.
Apoptosis was recently reported to be increased in the heart of acromegalic patients (47) . However, in the present study no signs of increased apoptosis could be detected. A possible explanation for the absence of apoptosis in our study might be that we only looked at one time-point, relatively late in the process of deterioration of cardiac structure and function and that apoptosis may indeed occur at an earlier stage.
It is important to point out that our data do not give us an exact information regarding the sequence of events in this study, i.e. whether the histologic and metabolic alterations into the myocardium are causative to or occur in parallel with the depression of cardiac function. Further studies with evaluation of cardiac morphology, performance, and myocardial energy status at different time points after exposure to GH excess are needed to clarify this issue. However, it is plausible to assume that while it cannot be proved that impaired energetics is the sole cause of decreased function, decreased myocardial energy stores can and does limit contraction. Therefore, this is likely to contribute to the depressed systolic function observed in our model.
Conclusions
Long-term exposure to high levels of GH increases cardiac mass and deteriorates cardiac systolic function. These effects are in close conjunction with bioenergetic abnormalities in the myocardium, suggesting that impaired high-energy phosphate metabolism can be an important mechanism behind the deterioration of cardiac function in acromegaly.
Limitations
Technical limitations only allow a cautious interpretation of data regarding Doppler recordings of mitral inflow with reference to diastolic function.
We used relatively old animals where irreversible changes have been shown to occur in other organs (28, 48 ) that could to some extent have influenced our results.
